Keith E. Dionne
39Patents
30h-index
48Co-inventors
81Inventor score
Filing activity: Jan 10, 1994 → Oct 4, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6083523A | Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products | Chemistry; Metallurgy | 442 | Expired |
| US5728396A | Sustained delivery of leuprolide using an implantable system | Human Necessities | 391 | Expired |
| US5985305A | Sustained delivery of an active agent using an implantable system | Human Necessities | 241 | Expired |
| US6261584A | Sustained delivery of an active agent using an implantable system | Human Necessities | 178 | Expired |
| US6375978B1 | Rate controlling membranes for controlled drug delivery devices | Human Necessities | 175 | Expired |
| US5972369A | Diffusional implantable delivery system | Human Necessities | 169 | Expired |
| US6287295A | Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems | Human Necessities | 140 | Expired |
| US5800828A | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products | Chemistry; Metallurgy | 138 | Expired |
| US6395292B2 | Sustained delivery of an active agent using an implantable system | Emerging Cross-Sectional Technologies | 129 | Expired |
| US5871767A | Methods for treatment or prevention of neurodegenerative conditions using immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core | Chemistry; Metallurgy | 126 | Expired |
| US6132420A | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems | Human Necessities | 119 | Expired |
| US5773286A | Inner supported biocompatible cell capsules | Chemistry; Metallurgy | 111 | Expired |
| US6113938A | Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents | Human Necessities | 103 | Expired |
| US6923800B2 | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems | Human Necessities | 101 | Expired |
| US5798113A | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products | Chemistry; Metallurgy | 99 | Expired |
| US6635268B2 | Sustained delivery of an active agent using an implantable system | Emerging Cross-Sectional Technologies | 97 | Expired |
| US5997527A | Self adjustable exit port | Human Necessities | 94 | Expired |
| US6156331A | Sustained delivery of an active agent using an implantable system | Human Necessities | 86 | Expired |
| US5550050A | Method for implanting encapsulated cells in a host | Chemistry; Metallurgy | 71 | Expired |
| US7207982B2 | Osmotic pump with means for dissipating internal pressure | Human Necessities | 67 | Expired |
| US6217906A | Self adjustable exit port | Human Necessities | 61 | Expired |
| US5834001A | Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core | Chemistry; Metallurgy | 53 | Expired |
| US8535701B2 | Sustained delivery of an active agent using an implantable system | Emerging Cross-Sectional Technologies | 49 | Active |
| US7655257B2 | Sustained delivery of an active agent using an implantable system | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5800829A | Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core | Chemistry; Metallurgy | 42 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.